コンテンツにスキップ

Pulmonary Adenocarcinoma: Approaches to Treatment, 1st Edition

著者 :
By Leora Horn, MD, MSc, MHPE
Get a quick, expert overview of the latest treatment and management approaches for adenocarcinoma of the lung, including novel therapeutics in immunotherapy and targeted therapies. This practical title, edited by Dr. Leora Horn, offers succinct cover ...view more

Get a quick, expert overview of the latest treatment and management approaches for adenocarcinoma of the lung, including novel therapeutics in immunotherapy and targeted therapies. This practical title, edited by Dr. Leora Horn, offers succinct coverage of clinically-focused topics and guidelines, making it an ideal resource for practicing and trainee oncologists and other members of the cancer care team.

ISBNコード :
9780323554343
出版日 :
24-10-2018
カートに入れる

!洋書籍は不課税のため消費税不適用、電子書籍は消費税がご注文決済前に表示・適用されます!

!洋書籍は不課税のため消費税不適用、電子書籍は消費税がご注文決済前に表示・適用されます!

Get a quick, expert overview of the latest treatment and management approaches for adenocarcinoma of the lung, including novel therapeutics in immunotherapy and targeted therapies. This practical title, edited by Dr. Leora Horn, offers succinct coverage of clinically-focused topics and guidelines, making it an ideal resource for practicing and trainee oncologists and other members of the cancer care team.


特長
  • Discusses surgical approaches, molecular testing, adjuvant therapy, first- and second-line therapy, and much more.
  • Helps you translate current research and literature into practical information for daily practice.
  • Consolidates today’s available information on this timely topic into one convenient resource.

著者情報
By Leora Horn, MD, MSc, MHPE
詳細情報
ISBN Number 9780323554343
Description Author List By Leora Horn, MD, MSc, MHPE
Copyright Year 2019
Edition Number 1
Format E-Book
Trim Other
Imprint Elsevier
Page Count 400
Publication Date 24 Oct 2018
Stock Status IN STOCK

Preface

1. Surgical Approaches

2. Pathology Considerations and Molecular Testing

3. Adjuvant Therapy

4. Treatment of locally advanced disease

5. First line therapy for wild type patients

6. Second-Line Therapy

7. Approach to EGFR mutation positive NSCLC

8. Approach to ALK positive NSCLC

9. Other Molecular Cohorts

10. Immunotherapy

あなたのレビューを投稿する
登録ユーザーのみがレビューを書くことができます。 ログインするか、アカウントを作成してください